Cargando…

Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer

BACKGROUND: The identification of prognostic tumor biomarkers that also would have potential as therapeutic targets, particularly in patients with early stage disease, has been a long sought-after goal in the management and treatment of lung cancer. The nuclear receptor (NR) superfamily, which is co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Yangsik, Xie, Yang, Xiao, Guanghua, Behrens, Carmen, Girard, Luc, Wistuba, Ignacio I., Minna, John D., Mangelsdorf, David J.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001894/ https://www.ncbi.nlm.nih.gov/pubmed/21179495 http://dx.doi.org/10.1371/journal.pmed.1000378

Ejemplares similares

Research Resource: Diagnostic and Therapeutic Potential of Nuclear Receptor Expression in Lung Cancer
por: Jeong, Yangsik, et al.
Publicado: (2012)

Molecular differences across invasive lung adenocarcinoma morphological subgroups
por: Ci, Bo, et al.
Publicado: (2020)

Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis
por: Kim, Jihye, et al.
Publicado: (2015)

Artificial Intelligence in Lung Cancer Pathology Image Analysis
por: Wang, Shidan, et al.
Publicado: (2019)

LCE: an open web portal to explore gene expression and clinical associations in lung cancer
por: Cai, Ling, et al.
Publicado: (2018)

Correction: LCE: an open web portal to explore gene expression and clinical associations in lung cancer
por: Cai, Ling, et al.
Publicado: (2019)

miR-93-directed down-regulation of DAB2 defines a novel oncogenic pathway in lung cancer
por: Du, Liqin, et al.
Publicado: (2013)

An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis
por: Hight, Suzie K., et al.
Publicado: (2020)

Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung
por: Yuan, Ping, et al.
Publicado: (2010)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells
por: Raymond, Aaron C., et al.
Publicado: (2019)

Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
por: Zang, Xiao, et al.
Publicado: (2015)

Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort Study
por: Luo, Xin, et al.
Publicado: (2019)

Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer
por: Wang, Shidan, et al.
Publicado: (2023)

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019)

CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
por: Rocha, Pedro, et al.
Publicado: (2021)

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer
por: Kim, Jin-Soo, et al.
Publicado: (2015)

Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
por: Rocha, Pedro, et al.
Publicado: (2021)

The evolving genomic classification of lung cancer
por: Shames, David S, et al.
Publicado: (2014)

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B
por: Cai, Ling, et al.
Publicado: (2019)

Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers
por: Huffman, Kenneth E., et al.
Publicado: (2023)

NSD3, a member of nuclear receptor‐binding SET domain family, is a potential prognostic biomarker for pancreatic cancer
por: Xiong, Qunli, et al.
Publicado: (2023)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
por: Pataer, Apar, et al.
Publicado: (2018)

Regulation of nutrient metabolism by nuclear receptor/FGF signaling pathways
por: Kliewer, Steven A, et al.
Publicado: (2012)

LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells
por: Wei, Q, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung
por: Prudkin, Ludmila, et al.
Publicado: (2009)

Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors
por: Rojas, Frank, et al.
Publicado: (2022)

Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways
por: Bookout, Angie L., et al.
Publicado: (2003)

High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
por: Massarelli, Erminia, et al.
Publicado: (2019)

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer
por: Ruder, Dennis, et al.
Publicado: (2018)

Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer
por: Shi, Bin, et al.
Publicado: (2019)

Towards defining the nuclear proteome
por: Fink, J Lynn, et al.
Publicado: (2008)

Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial–mesenchymal transition
por: Lin, Steven H, et al.
Publicado: (2014)

ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network
por: Wang, Shidan, et al.
Publicado: (2019)

Defining a standard set of patient-centred outcomes for lung cancer
por: Mak, Kimberley S., et al.
Publicado: (2016)

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer
por: Du, Liqin, et al.
Publicado: (2018)

Multiplatform-based Molecular Subtypes of Non-Small Cell Lung Cancer
por: Chen, Fengju, et al.
Publicado: (2016)

Comparing Statistical Methods for Constructing Large Scale Gene Networks
por: Allen, Jeffrey D., et al.
Publicado: (2012)

A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma
por: Cai, Ling, et al.
Publicado: (2023)

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
por: Cai, Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pci5vllpaeptt0le6tblk8sucb